MEGA BIOPHARMA — HomeFRContact

Products & development

Biomaterials.
Multiple opportunities.

Two distinct dental ranges: nacre-derived Bionacre® and Ostenova, which brings together a porcine-derived bone substitute and collagen membranes.

Our dental ranges

Bionacre® & Ostenova.
Two distinct ranges.

Bionacre® is developed from nacre. Ostenova brings together a porcine-derived bone substitute and collagen membranes. Each product follows its own pathway.

Nacre granules from the Bionacre Bone Graft programme

Nacre-derived range

Bionacre®
Bone Graft.

Our nacre-derived bone substitute programme, developed for filling bone defects in dental surgery.

In development · late preclinical stage

Explore the Bionacre® programme

Bone substitute & membranes

Ostenova.

A dental range in its own right.

Coming soon

Bone substitute

Ostenova Bone Graft — Granules: 0.5 · 1.0 · 2.0 cc
Granules: 0.5 · 1.0 · 2.0 cc0,25–1,0 mm
Ostenova Bone Graft — Granules: 0.5 · 1.0 · 2.0 cc
Granules: 0.5 · 1.0 · 2.0 cc1,0–2,0 mm
Ostenova Bone Graft — Syringes: 0.5 · 1.0 cc
Syringes: 0.5 · 1.0 cc0,25–1,0 mm

A porcine-derived bone substitute within the Ostenova range.

Contact the product team
Preparing for launch

Collagen membranes

Resorbable porcine collagen membranes in three sizes.

Discover the membranes
Ostenova Membrane — packaging 30 × 40 mm

BIONACRE® BONE GRAFT / DEVELOPMENT

A staged
regulatory pathway.

TODAY

Late preclinical stage

Material characterisation, biological assessments and preclinical studies support device development.

UNITED STATES

FDA · 510(k)

A pre-submission was completed in 2022. The programme is preparing the assessments and dossier needed for a future submission.

EUROPE

Clinical development

The strategy includes a clinical investigation to support the European pathway. The detailed roadmap is available on request.

Bionacre® Bone Graft is in development. A pre-submission or dossier submission does not constitute market authorisation.

Request the roadmap

Bionacre® platform opportunities

From bone
to cartilage.

One technology foundation, several research directions. Each application requires its own development and assessments.

Orthopaedics

Bone repair & fixation

Machined components, compact forms and potential applications in extremities, trauma and spine.

Research direction

Cartilage

Injectable formulations

Nacre-derived materials to explore cartilage and osteochondral repair, including injectable formats.

Research direction

Maxillofacial surgery

New reconstruction needs

Opportunities to evaluate with clinical and industrial partners.

Research direction
Blue Skincare Xéro-Nacre Nacre Cream

Our dermo-cosmetic brand

Blue Skincare.

Our nacre expertise also led to Blue Skincare, an established dermo-cosmetic skincare range for dry and fragile skin.

Discover Blue Skincare products

Let’s discuss your project

Let’s move
research forward.

Contact our team

MEGA BIOPHARMA

Cookies &
privacy.

This site does not include advertising, audience analytics or cross-site tracking tools.

Videos and fonts
Hosted with the site. No YouTube player or social media widget is loaded during your visit.
Your preference
If you click “Got it”, your browser stores only the dismissal of this notice for six months in local storage. This preference is not sent to a server.
Contacting us
The Contact form prepares an email in your email application. The Investor form sends your name, organisation, email and enquiry to FormSubmit only when you submit it; FormSubmit relays them to MEGA BIOPHARMA to respond to your enquiry. FormSubmit states that it retains submissions for 30 days. Its service and anti-spam check apply their own privacy policies. FormSubmit privacy

For questions about your data: dpo@megabiopharma.com